One study lasted 52 weeks and is considered to be the longest double-blind randomized trial to date for evaluating semaglutide for weight management
One important and still unanswered question relates to the potential mechanisms underlying GLP-1RA-related reduction of cancer risk in patients with type 2 diabetes
Interestingly, new research published in the journal Nature Medicine evaluated the health outcomes of more than 2 million veterans with diabetes taking a GLP-1 and found that while the medications had positive effects on several health conditions, like heart disease and substance use disorders, they were negatively associated with some, including arthritis
External resources Retatrutide: A Game Changer in Obesity Pharmacotherapy (PubMed Central) Triple Hormone Receptor Agonist Retatrutide for Metabolic Dysfunction (Nature Medicine) Handling and Storage Guidelines for Peptides and Proteins (Sigma-Aldrich) For researchers serious about optimizing their retatrutide protocols, SeekPeptides offers the most comprehensive resource available
However, injecting at the same time on the same day each week optimizes this stability
Retatrutide can lose 4060% of receptor-binding affinity without forming visible aggregates or changing color
